Universal American Corp. Announces 2009 Guidance
RYE BROOK, N.Y.--([ BUSINESS WIRE ])--Universal American Corp. (NYSE: UAM) today announced 2009 earnings per share guidance of between $1.47 and $1.57.
The following table provides additional information relating to our guidance.
FY 2009 | ||||
Low | High | |||
Diluted EPS | ||||
Operating EPS | $ 1.47 | $ 1.57 | ||
Shares Outstanding (millions) | 83.0 | 85.0 | ||
Revenue ($ in millions) | ||||
Senior Managed Care – Medicare Advantage | $2,705 | $2,905 | ||
Medicare Part D | 1,925 | 2,000 | ||
Traditional Insurance | 400 | 425 | ||
Total Revenue | $5,030 | $5,330 | ||
End of Year Membership | ||||
Medicare Advantage | ||||
Private fee-for-service | 190,000 | 210,000 | ||
HMOs/PPOs | 60,000 | 65,000 | ||
Subtotal Medicare Advantage | 250,000 | 275,000 | ||
Medicare Part D | 1,550,000 | 1,650,000 | ||
Total Membership | 1,800,000 | 1,925,000 | ||
Medicare Advantage Benefit Ratio | 83.0% | 85.5% |
This guidance will be discussed further at the J.P. Morgan Healthcare Conference, where Universal American is scheduled to present today at 7:30 a.m. Pacific Time. All interested parties are invited to listen to the webcast of the presentation by visiting [ www.universalamerican.com ] and selecting the Investor Relations tab, followed by Presentations. Following the conference, a webcast replay will be archived at [ www.universalamerican.com ].
To listen to the live webcast, please visit Universal American's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the webcast will be presumed to have read Universal American's most recent filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2007, and its Quarterly Reports on Form 10-Q for the reporting periods of 2008.
About Universal American Corp.
Universal American offers a diverse range of healthcare products – including health insurance, managed care, and prescription drug benefits – through its subsidiaries. Its companies are collectively among the leading providers of Medicare Advantage and Medicare prescription drug plans in the U.S., as over 2 million seniors rely on Universal American's products for their health or prescription drug coverage. For more information on Universal American, please visit our website at [ www.universalamerican.com ].
Matters discussed in this news release and oral statements made from time to time by representatives of Universal American may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although Universal American believes that the expectations reflected in any forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond Universal American's ability to control or predict. Important factors that may cause actual results to differ materially and could impact Universal American and the statements contained in this news release can be found in Universal American's filings with the Securities and Exchange Commission, including quarterly reports on Form 10-Q, current reports on Form 8-K and annual reports on Form 10-K. For forward-looking statements in this news release, Universal American claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Universal American assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise.